Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury

Traumatic brain injury (TBI) is a major risk factor for several neurodegenerative disorders, including Parkinson’s disease (PD) and Alzheimer’s disease (AD). Neuroinflammation is a cause of later secondary cell death following TBI, has the potential to aggravate the initial impact, and provides a th...

Cijeli opis

Bibliografski detalji

Glavni autori:	Shih Chang Hsueh, Michael T. Scerba, David Tweedie, Daniela Lecca, Dong Seok Kim, Abdul Mannan Baig, Yu Kyung Kim, Inho Hwang, Sun Kim, Warren R. Selman, Barry J. Hoffer, Nigel H. Greig
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2022-09-01
Serija:	Biomedicines
Teme:	pomalidomide immunomodulatory imide drugs (IMiDs) neuroinflammation traumatic brain injury cereblon
Online pristup:	https://www.mdpi.com/2227-9059/10/10/2449
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!